Compagnie Lombard Odier SCmA’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-1,240	Closed	-$103K	–	505
2025 Q2	$103K	Hold	1,240	–	–	﹤0.01%	285
2025 Q1	$101K	Sell	1,240 -2,400	-66%	-$215K	﹤0.01%	304
2024 Q4	$328K	Buy	3,640 +1,240	+52%	+$120K	﹤0.01%	207
2024 Q3	$237K	Sell	2,400 -575	-19%	-$56.5K	﹤0.01%	229
2024 Q2	$276K	Hold	2,975	–	–	﹤0.01%	215
2024 Q1	$282K	Hold	2,975	–	–	0.01%	227
2023 Q4	$266K	Hold	2,975	–	–	﹤0.01%	257
2023 Q3	$217K	Buy	2,975 +2,400	+417%	+$192K	0.01%	257
2023 Q2	$47.8K	Buy	+575	New	+$48.1K	﹤0.01%	417
2022 Q4	–	Hold	0	–	–	–	743
2022 Q3	–	Sell	-2,728	Closed	-$230K	–	740
2022 Q2	$202K	Buy	+2,728	New	+$205K	0.01%	292
2018 Q4	–	Sell	-300	Closed	-$29K	–	622
2018 Q3	$29K	Sell	300 -1,230	-80%	-$119K	﹤0.01%	469
2018 Q2	$146K	Sell	1,530 -20	-1%	-$1.84K	0.01%	319
2018 Q1	$136K	Sell	1,550 -2,050	-57%	-$187K	0.01%	347
2017 Q4	$304K	Sell	3,600 -11,440	-76%	-$958K	0.01%	348
2017 Q3	$1.3M	Sell	15,040 -4,530	-23%	-$363K	0.05%	197
2017 Q2	$1.51M	Buy	19,570 +300	+2%	+$21.3K	0.05%	194
2017 Q1	$1.34M	Sell	19,270 -6,300	-25%	-$423K	0.05%	203
2016 Q4	$1.51M	Buy	25,570 +1,000	+4%	+$61.7K	0.04%	214
2016 Q3	$1.63M	Buy	24,570 +14,770	+151%	+$914K	0.05%	209
2016 Q2	$530K	Buy	9,800 +9,500	+3,167%	+$521K	0.02%	333
2016 Q1	$15K	Hold	300	–	–	﹤0.01%	851
2015 Q4	$21K	Hold	300	–	–	﹤0.01%	799
2015 Q3	$19K	Hold	300	–	–	﹤0.01%	706
2015 Q2	$25K	Hold	300	–	–	﹤0.01%	695
2015 Q1	$23K	Buy	+300	New	+$21K	﹤0.01%	851